Cargando…
Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-versus-Host Disease and Preserves Anti-Tumor Effects
Graft versus host disease (GVHD) is an immunological disorder triggered by bone marrow transplantation that affects several organs, including the gastrointestinal tract and liver. Fullerenes and their soluble forms, fullerols, are nanocomposites with a closed symmetrical structure with anti-inflamma...
Autores principales: | Bernardes, Priscila T. T., Rezende, Bárbara M., Resende, Carolina B., De Paula, Talles P., Reis, Alesandra C., Gonçalves, William A., Vieira, Elias G., Pinheiro, Maurício V. B., Souza, Danielle G., Castor, Marina G. M., Teixeira, Mauro M., Pinho, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395348/ https://www.ncbi.nlm.nih.gov/pubmed/25875016 http://dx.doi.org/10.1371/journal.pone.0123004 |
Ejemplares similares
-
Lithothamnion muelleri Controls Inflammatory Responses, Target Organ Injury and Lethality Associated with Graft-versus-Host Disease in Mice
por: Rezende, Barbara M., et al.
Publicado: (2013) -
Inhibition of 5-lipoxygenase alleviates graft-versus-host disease
por: Rezende, Barbara Maximino, et al.
Publicado: (2017) -
Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice
por: Rezende, Barbara Maximino, et al.
Publicado: (2019) -
Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a
developing country: lower rate of acute GVHD, increased risk of cytomegalovirus
reactivation
por: Resende, C.B., et al.
Publicado: (2017) -
The Role of Chemokines in Mediating Graft Versus Host Disease: Opportunities for Novel Therapeutics
por: Castor, Marina G. M., et al.
Publicado: (2012)